215 related articles for article (PubMed ID: 35504656)
1. Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-
Betterton RD; Abdullahi W; Williams EI; Lochhead JJ; Brzica H; Stanton J; Reddell E; Ogbonnaya C; Davis TP; Ronaldson PT
Drug Metab Dispos; 2022 Jul; 50(7):942-956. PubMed ID: 35504656
[TBL] [Abstract][Full Text] [Related]
2. Functional Expression of Organic Anion Transporting Polypeptide 1a4 Is Regulated by Transforming Growth Factor-
Abdullahi W; Brzica H; Hirsch NA; Reilly BG; Ronaldson PT
Mol Pharmacol; 2018 Dec; 94(6):1321-1333. PubMed ID: 30262595
[TBL] [Abstract][Full Text] [Related]
3. Transport Properties of Statins by Organic Anion Transporting Polypeptide 1A2 and Regulation by Transforming Growth Factor-
Ronaldson PT; Brzica H; Abdullahi W; Reilly BG; Davis TP
J Pharmacol Exp Ther; 2021 Feb; 376(2):148-160. PubMed ID: 33168642
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery.
Thompson BJ; Sanchez-Covarrubias L; Slosky LM; Zhang Y; Laracuente ML; Ronaldson PT
J Cereb Blood Flow Metab; 2014 Apr; 34(4):699-707. PubMed ID: 24473481
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor.
Abdullahi W; Brzica H; Ibbotson K; Davis TP; Ronaldson PT
J Cereb Blood Flow Metab; 2017 Jul; 37(7):2340-2345. PubMed ID: 28387157
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier.
Ronaldson PT; Finch JD; Demarco KM; Quigley CE; Davis TP
J Pharmacol Exp Ther; 2011 Mar; 336(3):827-39. PubMed ID: 21131267
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific differences in organic anion transporting polypeptide 1a4 (Oatp1a4) functional expression at the blood-brain barrier in Sprague-Dawley rats.
Brzica H; Abdullahi W; Reilly BG; Ronaldson PT
Fluids Barriers CNS; 2018 Sep; 15(1):25. PubMed ID: 30208928
[TBL] [Abstract][Full Text] [Related]
8. Oatp (Organic Anion Transporting Polypeptide)-Mediated Transport: A Mechanism for Atorvastatin Neuroprotection in Stroke.
Williams EI; Betterton RD; Stanton JA; Moreno-Rodriguez VM; Lochhead JJ; Davis TP; Ronaldson PT
Stroke; 2023 Nov; 54(11):2875-2885. PubMed ID: 37750296
[TBL] [Abstract][Full Text] [Related]
9. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
Abdullahi W; Davis TP; Ronaldson PT
AAPS J; 2017 Jul; 19(4):931-939. PubMed ID: 28447295
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/β-catenin and endothelin-1 signaling.
Harati R; Benech H; Villégier AS; Mabondzo A
Mol Pharm; 2013 May; 10(5):1566-80. PubMed ID: 22998451
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y
Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843
[TBL] [Abstract][Full Text] [Related]
12. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
Storelli F; Billington S; Kumar AR; Unadkat JD
Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview.
Balasubramanian R; Maideen NMP
Curr Drug Metab; 2021; 22(5):328-341. PubMed ID: 33459228
[TBL] [Abstract][Full Text] [Related]
14. Comparative Hepatic and Intestinal Efflux Transport of Statins.
Deng F; Tuomi SK; Neuvonen M; Hirvensalo P; Kulju S; Wenzel C; Oswald S; Filppula AM; Niemi M
Drug Metab Dispos; 2021 Sep; 49(9):750-759. PubMed ID: 34162690
[TBL] [Abstract][Full Text] [Related]
15. Results From Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3.
Heinig R; Fricke R; Wertz S; Nagelschmitz J; Loewen S
Eur J Drug Metab Pharmacokinet; 2022 Nov; 47(6):803-815. PubMed ID: 36029368
[TBL] [Abstract][Full Text] [Related]
16. Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats.
Yaguchi Y; Tachikawa M; Zhang Z; Terasaki T
Mol Pharm; 2019 May; 16(5):2021-2027. PubMed ID: 30977661
[TBL] [Abstract][Full Text] [Related]
17. pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.
Varma MV; Rotter CJ; Chupka J; Whalen KM; Duignan DB; Feng B; Litchfield J; Goosen TC; El-Kattan AF
Mol Pharm; 2011 Aug; 8(4):1303-13. PubMed ID: 21710988
[TBL] [Abstract][Full Text] [Related]
18. Solute Carrier Family of the Organic Anion-Transporting Polypeptides 1A2- Madin-Darby Canine Kidney II: A Promising In Vitro System to Understand the Role of Organic Anion-Transporting Polypeptide 1A2 in Blood-Brain Barrier Drug Penetration.
Liu H; Yu N; Lu S; Ito S; Zhang X; Prasad B; He E; Lu X; Li Y; Wang F; Xu H; An G; Unadkat JD; Kusuhara H; Sugiyama Y; Sahi J
Drug Metab Dispos; 2015 Jul; 43(7):1008-18. PubMed ID: 25908246
[TBL] [Abstract][Full Text] [Related]
19. Impact of Zn
Zaremba A; Helm F; Fricker G
Mol Pharm; 2019 Jan; 16(1):305-317. PubMed ID: 30422662
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.
Ieiri I; Higuchi S; Sugiyama Y
Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):703-29. PubMed ID: 19442037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
